-+ 0.00%
-+ 0.00%
-+ 0.00%

NEXALIN TECHNOLOGY COMPLETES FDA Q-SUBMISSION MEETING FOR GEN-2 SYNC™ NEUROSTIMULATION CONSOLE IN ALZHEIMER’S DISEASE PROGRAM

路透·12/03/2025 13:00:55

登录查看新闻详情